Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 84

Results For "EMA"

2248 News Found

Lupin, Cost Plus Drug and COPD Foundation to expand access to medication for COPD patients
Healthcare | September 07, 2023

Lupin, Cost Plus Drug and COPD Foundation to expand access to medication for COPD patients

This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US


Apollo introduces India's first comprehensive Connected Care Services
Healthcare | September 05, 2023

Apollo introduces India's first comprehensive Connected Care Services

This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition


Caplin Steriles receives EIR from US FDA
Drug Approval | September 05, 2023

Caplin Steriles receives EIR from US FDA

The inspection classification was determined by the agency as Voluntary Action Indicated


BioNTech to lead $2 billion mRNA-based oncology therapy market despite challenges, says GlobalData
News | September 03, 2023

BioNTech to lead $2 billion mRNA-based oncology therapy market despite challenges, says GlobalData

BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials


Loop's health assurance model drives 200% YoY premium surge across 1000 companies
Healthcare | September 02, 2023

Loop's health assurance model drives 200% YoY premium surge across 1000 companies

Health Assurance is a unique healthcare model that combines health insurance with preventive healthcare with a focus on keeping people healthy while providing sick care for them when needed


Shilpa Pharma Lifesciences’ Unit II, Raichur, Karnataka clears PMDA Japan, GMP inspection
Drug Approval | September 02, 2023

Shilpa Pharma Lifesciences’ Unit II, Raichur, Karnataka clears PMDA Japan, GMP inspection

The inspection has concluded successfully on 1st September 2023 without any critical/major observation


Sanofi, Meningitis Research Foundation and CoMO launch awareness initiative on meningitis
News | September 01, 2023

Sanofi, Meningitis Research Foundation and CoMO launch awareness initiative on meningitis

Meningitis still affects more than 2.5 million people globally each year


USFDA approves BMS’ Reblozyl as first-line treatment of anemia in adults with Myelodysplastic Syndromes
Drug Approval | September 01, 2023

USFDA approves BMS’ Reblozyl as first-line treatment of anemia in adults with Myelodysplastic Syndromes

Reblozyl is the first and only therapy to demonstrate superiority compared to an erythropoiesis stimulating agent (ESA) in MDS-related anemia


Elekta and IAEA partner to improve access to cancer care in underserved countries
Healthcare | September 01, 2023

Elekta and IAEA partner to improve access to cancer care in underserved countries

Dr. Laurent Leksell, Elekta’s Founder and Chairman of the Board, and IAEA’s Director General, Dr. Rafael Mariano Grossi meet in Stockholm to discuss reducing the global cancer burden